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PreviewsIt remains to be seen whether ROS
production can be compartmentalized
to bias killing of pathogenic bacteria
and sparing commensal microflora, or
whether the inflammatory process is
indiscriminate with regard to bacterial
class. A recent study found that
commensal lactobacilli stimulate stem
cell proliferation via ROS produced by
another synthetic enzyme, Nox, in both
flies and mammals (Jones et al.,
2013). Since lactobacilli do not induce
DUOX via activation of the signaling en-
dosome, it is intriguing how ROS pro-
duced via these two different pathways
can lead to alternative cellular re-
sponses. Another remaining puzzle is
how or why uracil secretion represents
an accurate indicator of potentially
pathogenic species (Lee et al., 2013),
and what mechanisms might be
responsible for suppressing uracil148 Cell Host & Microbe 17, February 11, 201secretion in different commensal spe-
cies (e.g., altered synthesis, transport,
metabolism, or sequestration). Certainly
additional pathogen signals beyond ura-
cil may feed into the identified path-
ways, and/or alternative signals pro-
duced by commensal bacteria could
dampen immune responses at baseline
to defend the gut epithelium against
ROS damage. These may be productive
avenues to build upon the key ad-
vances of this work and to investigate
in diverse model systems including
mammals.REFERENCES
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In this issue of Cell Host & Microbe, Huang et al. (2015) and Guo et al. (2015), along with recent work byWang
et al. (2014), reveal that HSV ribonucleotide reductase has opposing activities in either inducing or preventing
necroptosis, depending on the host species. This evolutionary twist underscores the importance of selective
pressure in virus-host relationships.The induction of cell death in response to
viral pathogens represents a powerful
component of the host defense machin-
ery. It is of no surprise that viruses have
evolved potent counterdefense mecha-
nisms. The best-studied cell death
pathway is apoptosis, characterized by
its dependence on caspase activation.
Apoptosis has long been recognized as
an important antiviral mechanism, by
efficiently and ‘‘quietly’’ clearing dying
cells. Multicellular organisms prevent the
spread of viral infections by inducing
apoptosis, and viruses, in turn, have
evolved mechanisms to block caspaseactivation, thereby preventing apoptosis
(reviewed in Chan et al., 2014). In
response, mammalian hosts have
evolved a backup mechanism, pro-
grammed necrosis or necroptosis, to kill
cells and limit viral spread. This defense
and counterdefense tug of war reflects a
robust evolutionary arms race between
hosts and their pathogens that continues
to escalate.
Apoptosis and necroptosis pathways
are interconnected, and the balance
between the two is tightly regulated.
Stimulation of the death receptors in the
tumor necrosis factor (TNF) family leadsto activation of apoptosis via caspase-8,
which also prevents necroptosis by
cleaving the adaptor proteins receptor-
interacting kinase 1 (RIP1) and RIP3.
Under conditions in which caspase-8 is
inhibited, RIP1 can engage with its part-
ner RIP3 through their RIP homotypic
interaction motifs (RHIMs), forming a
multiprotein complex termed the ne-
crosome. Here, RIP3 kinase is acti-
vated, resulting in the phosphorylation
of the mixed lineage kinase domain-
like (MLKL) protein, leading to MLKL
complex formation and eventual mem-
brane disruption (Figure 1A) (reviewed
Figure 1. Viral Modulation of Necroptosis
(A) Multiple sensing pathways activated during viral infection contain adaptor proteins with RHIM do-
mains. Inactivation of caspase-8 and apoptosis leads to canonical (RIP1-RIP3) and/or noncanonical
(DAI-RIP3 and TRIF-RIP3) necrosome formation. Activated RIP3 recruits and phosphorylates MLKL, re-
sulting in membrane disruption and necroptosis. In response to HSV, necroptosis is partially dependent
on RIP1, while RIP3 and MLKL are essential.
(B) In mouse cells, HSV R1 forms dimers or oligomers through its C-terminal domain. R1 dimers or
oligomers induce RIP1-RIP3 and RIP3-RIP3 necrosome complexes in a RHIM-dependent fashion,
activating necroptosis. While DAI and TLR3 are not essential to trigger necroptosis in HSV-infectedmouse
cells, ICP6 can interact with DAI in a RHIM-dependent fashion. It is currently unclear whether DAI-RIP3 or
TRIF-RIP3 contribute to HSV-mediated necroptosis (hatched box), as observed in MCMV-infected cells.
Paradoxically, in human cells, HSV R1 RHIM-mediated binding to RIP1 and RIP3 blocks necrosome
formation and subsequent necroptosis. The requirement for HSV R1 dimer or oligomer formation in this
process is not clear.
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Previewsin Chan et al., 2014). Although the
canonical pathway leading to necrop-
tosis occurs via the TNF pathway, it is
now clear that necroptosis can be
induced via multiple innate immunesensing pathways. Following activation
by a variety of stimuli, RHIM-containing
adaptors such as RIP1, TRIF, or
the DNA activator of interferon (DAI)
can interact with RIP3 to induce ne-Cell Host & Microbe 17,crosome formation and phosphorylate
MLKL (Figure 1A).
In three recent papers, including two
in this issue of Cell Host & Microbe
and one in the October 28, 2014, issue
of Proceedings of the National Academy
of Sciences, we learn that the ability of
a virus to induce or subvert necroptosis
depends on the evolutionary history be-
tween the virus and the host (Guo
et al., 2015; Huang et al., 2015; Wang
et al., 2014). The viral superheros in the
evolutionary tug of war described in
these papers are HSV-1 ICP6 and
HSV-2 ICP10, collectively referred to as
HSV R1. HSV R1 was initially identified
as the large subunit of the viral ribonucle-
otide reductase (RNR), which catalyzes
the formation of deoxyribonucleotides
from ribonucleotides, a particularly
important function for large DNA viruses.
It appears that HSV R1 was picked up
from a host cell (reviewed in Lembo
and Brune, 2009) and likely retained
because it confers an evolutionary
advantage, especially in cells in which
the cellular RNR is not expressed. In
fact, HSV-1 ICP6 is essential for HSV-1
growth in nondividing Vero cells (Gold-
stein and Weller, 1988). It has become
clear that ICP6 has continued to evolve
in response to continued evolutionary
pressure and has adopted multiple
functions.
Both ICP6 and ICP10 encode an N-ter-
minal 400 aa extension not found in R1
subunits of other RNR proteins (Lembo
and Brune, 2009). This extension contains
an alpha-crystallin domain reminiscent of
a sequence found in small heat-shock
proteins such as hsp27, and purified
ICP6 can function as a chaperone in ther-
mal denaturation assays (Chabaud et al.,
2003). Furthermore, ICP6 was shown
to stimulate initiation of translation in
growth-arrested primary human cells by
promoting eIF4F assembly (Walsh and
Mohr, 2006). Interestingly, RNR and
translation-promotion functions of ICP6
are required in nondividing human cells.
Also within the N terminus is a RHIM
domain (Figure 1B) found in proteins that
can interact with the kinase RIP3, the pri-
mary inducer of necroptosis. The C termi-
nus also contains additional functional
domains that mediate ICP6 dimer forma-
tion and ICP6 binding and inhibition of
caspase-8, suppressing apoptosis (Du-
four et al., 2011).February 11, 2015 ª2015 Elsevier Inc. 149
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PreviewsSeveral viruses, including vaccinia and
murine cytomegalovirus (MCMV), encode
proteins that inhibit apoptosis, thereby
sensitizing infected cells to necroptosis
(reviewed in Chan et al., 2014). MCMV en-
codes a RHIM-containing protein (vIRA/
M45) that inhibits necroptosis in mouse
cells (Upton et al., 2010, 2012). Interest-
ingly, M45 is a homolog of HSV R1;
however, it is not functional as a RNR
(reviewed in Lembo and Brune, 2009),
perhaps because the evolutionary pres-
sure to maintain RNR activity is less for
MCMV and other beta herpesviruses
that replicate in dividing cells. However,
the RHIM domain in M45 has been main-
tained, presumably because of its
importance in inhibiting RIP-mediated
necroptosis.
In the Wang et al. (2014) and Huang
et al. (2015) papers, we learn that HSV-1
triggers RIP3/MLKL-dependent necrop-
tosis in mouse cells by a mechanism
that is independent of the receptor for
TNF (TNFR), DAI, or the innate receptor
TLR3. To activate RIP3-mediated necrop-
tosis, ICP6 dimerizes or oligomerizes
through its C-terminal RNR domain and
then interacts with RIP1 and RIP3 through
its N-terminal RHIM domain, resulting in
the formation of RIP1-RIP3 and RIP3-
RIP3 complexes that phosphorylate
MLKL and induce necroptosis (Figure 1B,
left panel) (Wang et al., 2014). Mice lack-
ing RIP3 exhibit increased permissivity
against HSV-1, consistent with the notion
that necroptosis is antiviral. Thus ICP6
induces necroptosis in mouse cells,
whereas its homolog M45 suppresses
necroptosis.
The plot thickens, however, with the
interesting observation made by both
the Han and Mocarski groups that, in
contrast to mouse cells in which both
ICP6 and ICP10 induce necroptosis, the
opposite scenario plays out in human
cells (Guo et al., 2015; Huang et al.,
2015). In human cells, ICP6 and ICP10
disrupt the interaction between RIP1 and
RIP3 and inhibit necroptosis in a RHIM-
dependent fashion (Figure 1B, right
panel). Interestingly, inhibition of necrop-
tosis in human cells requires both the
RHIM and caspase-8 binding domains of
ICP6. This fascinating observation ap-
pears to reflect the fact that the natural
host for HSV-1 and HSV-2 is humans,
and during the long association between
virus and host, the RHIM of HSV has150 Cell Host & Microbe 17, February 11, 201evolved to counteract the antiviral activ-
ities of RIPs.
Viral and cellular RHIM sequences
appear to be extremely important deter-
minants of whether pro- or antinecrop-
totic pathways are induced, raising
questions about the evolution of this
important motif. Viral RHIM domains in
M45, ICP6, and ICP10 contain a hydro-
phobic tetrapeptide core similar to RHIM
domains found in mammalian RHIM
adaptors (V/IQIG) (Chan et al., 2014).
Interestingly, the tetrapeptide motifs in
ICP6 and ICP10 both contain a cysteine
in the third position (VQCG) and another
cysteine just outside the tetrapeptide
motif (Chan et al., 2014; Lembo and
Brune, 2009). Given the observed ability
of ICP6 and ICP10 to prevent necroptosis
in human but not mouse cells, it will be
interesting to determine whether these
sequence differences are responsible for
the antinecroptotic effect in human cells.
Another interesting observation is that
both the RHIM and the C-terminal RNR
domains of HSV R1 are required for sup-
pression of necroptosis. The C-terminal
portion of HSV R1 contains the RNR cata-
lytic domain as well as residues required
for HSV R1 dimerization and caspase-8
binding and inhibition. Although it is clear
that RNR catalytic function is not required
for suppression of necroptosis, it will be of
interest to determine the precise role
played by the C terminus in this process.
Moreover, although DAI and TLR3 are
not required for RIP3-dependent necrop-
tosis in HSV-infected mouse cells, ICP6
can bind DAI in a RHIM-dependent
fashion. This observation raises the ques-
tion of whether DAI and TRIF play any role
in HSV-triggered necroptosis (Figure 1B);
indeed, both adaptors play leading roles
in MCMV-triggered necroptosis (Upton
et al., 2010, 2012). Finally, R1 null viruses
are the backbone of many oncolytic HSV
vectors under development as novel can-
cer therapeutics, based on their preferen-
tial replication in actively dividing cells and
ability to induce immunogenic forms of
cell death, a key element in activating
long-lasting antitumor immunity (Inoue
and Tani, 2014). Thus, understanding
how viruses modulate hosts death path-
ways can influence effective therapy
design.
Apoptosis is a well-conserved cell
death mechanism found in all eu-
karyotic organisms, from Drosophila and5 ª2015 Elsevier Inc.C. elegans to higher eukaryotes. On the
other hand, the necroptotic pathway
has evolved more recently. Although
adapters with RHIM-like motifs have
been described in Drosophila, these pro-
teins differ from those found in higher eu-
karyotes both in the amino residues within
the RHIM domain itself and in the lack of a
kinase domain. As a result of gene dupli-
cation, mammalian cells encode several
RHIM adapters, including RIP1, RIP3,
TRIF, and DAI. It is possible that mamma-
lian necroptosis has evolved as a result of
evolutionary pressure from viral infections
that are able to prevent apoptosis (Chan
et al., 2014). The experiments presented
in these three papers provide strong sup-
port for this notion, since HSV-1 and
HSV-2 only inhibit necroptosis in their nat-
ural hosts and not in mice.
These three papers reveal a complex
evolutionary scenario that can be summa-
rized as follows: (1) apoptosis evolved
in part as a mechanism to limit virus
spread; (2) viral mechanisms evolved
to suppress apoptosis by binding to and
inhibiting caspase-8; (3) necroptosis
evolved as a backup mechanism to coun-
teract infection by viruses that evolved
to inhibit apoptosis; and (4) HSV-1 and
HSV-2 have evolved to suppress necrop-
tosis in their natural hosts. These papers
provide a powerful example illustrating
the role of death programs in protecting
organisms from pathogens and the
remarkable ability of pathogens to over-
come these antiviral mechanisms in their
natural hosts. Furthermore, these obser-
vations should strike a cautionary note
with respect to using nonnatural hosts
such as mice to study human viral
pathogenesis.ACKNOWLEDGMENTS
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